milrinone has been researched along with cardiovascular agents in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Evenou, JP; Hof, A; Hof, RP; Novosel, D | 1 |
| Bentley, RG; Canniff, PC; Farah, AE; Frangakis, CJ | 1 |
| Goldberg, LI | 1 |
| Carlier, J; D'Orio, V; el Allaf, D | 1 |
| He, GW; Yang, CQ | 1 |
| Araki, S; Gotanda, K; Hashimoto, H; Matsuzaki, T; Nagashima, S; Nakashima, M; Ochiai, H; Uematsu, T | 1 |
| Asakura, M; Asanuma, H; Fukushima, T; Hori, M; Kitakaze, M; Kuzuya, T; Liao, Y; Mori, H; Node, K; Ogai, A; Ogita, H; Papst, PJ; Sakata, Y; Sanada, S; Shinozaki, Y; Takashima, S; Terada, N; Yamada, J | 1 |
| Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
| Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J | 1 |
| Dec, GW | 1 |
| Christensen, M; Connolly, S; Goday, PS; Manzi, J; Mikhailov, TA; Panchal, AK; Wakeham, M | 1 |
| Boddu, SH; Churchwell, MD; Howard, MS; Mauro, VF | 1 |
| McGovern, E; McMahon, CJ; Moylett, E | 1 |
| Lim, SY; Morishita, K; Morita, T; Nakamura, K; Ohta, H; Osuga, T; Takiguchi, M; Yokoyama, N | 1 |
| Antzelevitch, C; Barajas-Martinez, H; Gurabi, Z; Hu, D; Koncz, I; Patocskai, B | 1 |
| Eagle, SS; Staudt, GE | 1 |
| Cheng, GL; Li, J; Li, LF; Peng, T; Ren, YS; Sun, Y; Tan, YJ; Zhang, GM | 1 |
| Griffith, SN; Mruk, A; Padilla, S; Stapleton, E; Thomas, CA | 1 |
3 review(s) available for milrinone and cardiovascular agents
| Article | Year |
|---|---|
Advances in cardiovascular pharmacology.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aminopyridines; Amrinone; Animals; Calcium Channel Blockers; Cardiovascular Agents; Dopamine; Heart Rate; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones; Receptors, Histamine; Vasodilator Agents | 1984 |
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
The effect of milrinone on mortality in adult patients who underwent CABG surgery: a systematic review of randomized clinical trials with a meta-analysis and trial sequential analysis.
Topics: Adult; Aged; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Milrinone; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Treatment Outcome | 2020 |
1 trial(s) available for milrinone and cardiovascular agents
| Article | Year |
|---|---|
Cardiac and hemodynamic effects of TZC-5665, a novel pyridazinone derivative, and its metabolite in humans and dogs.
Topics: Adult; Animals; Area Under Curve; Cardiovascular Agents; Dogs; Electrocardiography; Female; Half-Life; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Myocardium; Pyridazines; Pyridones; Stimulation, Chemical | 1997 |
14 other study(ies) available for milrinone and cardiovascular agents
| Article | Year |
|---|---|
Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure.
Topics: Animals; Autonomic Nervous System; Cardiovascular Agents; Disease Models, Animal; Enalapril; Heart Failure; Heart Rate; Milrinone; Myocardial Contraction; Nitroprusside; Ouabain; Propranolol; Pyridones; Rabbits; Vagotomy; Vasodilator Agents | 1992 |
The effect of extracellular Ca2+ and related ions on the cardiac action of milrinone.
Topics: Action Potentials; Animals; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Dogs; Drug Interactions; Heart; In Vitro Techniques; Membrane Potentials; Milrinone; Myocardial Contraction; Norepinephrine; Potassium; Pyridones | 1988 |
Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Arteries; Cardiovascular Agents; Coronary Artery Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1996 |
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Flow Velocity; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Cardiovascular Agents; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dogs; Enzyme Inhibitors; Flavonoids; Hemodynamics; Imidazoles; Indoles; Isoquinolines; Maleimides; Milrinone; Mitogen-Activated Protein Kinases; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Pyridones; Sulfonamides; Ventricular Fibrillation | 2001 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome | 2005 |
Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents.
Topics: Adolescent; Cardiovascular Agents; Child; Child, Preschool; Critical Illness; Dobutamine; Dopamine; Enteral Nutrition; Epinephrine; Female; Gastrointestinal Tract; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Logistic Models; Male; Milrinone; Norepinephrine; Retrospective Studies; Vasopressins | 2016 |
Compatibility of conivaptan injection with select cardiovascular medications.
Topics: Benzazepines; Cardiovascular Agents; Contraindications; Dobutamine; Dopamine; Drug Combinations; Drug Incompatibility; Humans; Infusions, Intravenous; Milrinone; Nitroglycerin | 2014 |
Myocardial ischaemia following cocaine and adrenaline exposure in a child during an ophthalmological procedure.
Topics: Administration, Topical; Anesthetics, Local; Cardiovascular Agents; Cocaine; Diagnostic Techniques, Ophthalmological; Epinephrine; Female; Humans; Infant; Lacrimal Apparatus Diseases; Milrinone; Mydriatics; Myocardial Ischemia; Nitroglycerin; Treatment Outcome | 2015 |
Effects of various cardiovascular drugs on indices obtained with two-dimensional speckle tracking echocardiography of the left atrium and time-left atrial area curve analysis in healthy dogs.
Topics: Animals; Area Under Curve; Atrial Function, Left; Cardiovascular Agents; Dobutamine; Dogs; Echocardiography; Female; Male; Milrinone; Phenylephrine; Propanolamines | 2015 |
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sudden, Cardiac; Disease Models, Animal; Dogs; Electrocardiography; Ion Channels; Isoproterenol; Milrinone; Tachycardia, Ventricular; Tetrazoles; Ventricular Fibrillation | 2016 |
A Tale of 2 Inodilators: Much Ado About Nothing?
Topics: Cardiac Surgical Procedures; Cardiovascular Agents; Child; Heart; Humans; Milrinone; Simendan | 2020 |
Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration.
Topics: Cardiotonic Agents; Cardiovascular Agents; Chemistry, Pharmaceutical; Drug Incompatibility; Humans; Infusions, Intravenous; Milrinone; Prospective Studies | 2020 |